Clinical Trials Sponsored by Institut de Cancérologie de la Loire

Total 2309 results

Institut de Cancérologie de la Loire

Completed

The Treatment of Addictions in the Course of Care in Oncology: an Inventory of Fixtures Among Paramedical Professionals (PREFACE)

Paramedical Professional

France
Institut de Cancérologie de la Loire

Completed

Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma

France
Institut de Cancérologie de la Loire

Completed

Informed Decision Users of the Health System and Participation in Organized Screening for Breast Cancer (DECIDEO)

Healthy | Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (VIRAUTO6)

Hematologic Diseases

France
Institut de Cancérologie de la Loire

Completed

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Screening for Social Weaknesses and Coordination Course of Cancer Patients (DEFCOCANCERO)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation (Nutriprophy)

Prostate Cancer

France
Institut de Cancérologie de la Loire

Terminated

Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia (QUALI)

Elderly Patients | Systemic Treatment | Metastatic Neoplasia

France
Institut de Cancérologie de la Loire

Completed

GRAFted Patients' anxieTY Report (GRAFTY)

Autologous Transplant Indication

France
Institut de Cancérologie de la Loire

Unknown

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse (TIPA)

Breast Neoplasms
Institut de Cancérologie de la Loire

Completed

Representations and Prevention of Cancers in Schools (RISCOLAIRE)

Healthy
Institut de Cancérologie de la Loire

Completed

Impact of Media Images, Alcohol and Tobacco to Youth (IMAJE)

Healthy
Institut de Cancérologie de la Loire

Completed

Cancer Fatigue Education Program

Patient With Histologically Confirmed Malignancy

France
Institut de Cancérologie de la Loire
Hôpital Privé de la Loire

Unknown

Evaluation of a Telephone Care Nurse in the Management of Patients With Cancer and Treated by Oral Chemotherapy (ETICCO)

Cancer

France
Institut de Cancérologie de la Loire
Celgene Corporation

Completed

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia (RV-405 LAL)

Leukemia, Lymphoid | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

France
Institut de Cancérologie de la Loire
Hospices Civils de Lyon

Completed

Development of a Therapeutic Education Program for Patients Operated for Prostate Cancer (PEPs PROSTATE)

Prostate Cancer

France
Institut de Cancérologie de la Loire
National Cancer Institute, France

Unknown

I2S-Health Prevention (I2S)

Secondary School Student in General High School Who Does Not Have a Disability That Does Not Allow a Good Understanding of the Study Requirements

United States, France
Institut de Cancérologie de la Loire
Laboratoire ACTé; Education Nationale

Unknown

Interventional Research in Schools - Second Part (RISCOLAIRE2)

Healthy
Institut de Cancérologie de la Loire
Centre Hospitalier Lyon Sud

Completed

Safe Infusion Device in Reducing Occupational Exposure of Nurses (CONTAMOINS-1)

Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Administration of Fibrinogen Concentrate for Refractory Bleeding (FORMAT)

Bleeding | Platelet Refractoriness | Hematological Patients

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Terminated

Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy (GASTROXY)

Cancer | Feeding Disorders

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment (IRMYG)

Multiple Myeloma | Renal Failure

France, Belgium, Algeria, Lebanon
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne

Unknown

Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study (RECAP 2)

Broncho Pulmonary Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia (PHARM-LMC)

Chronic Myeloid Leukemia

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Terminated

Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Cardio-vascular Surgery

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Evolution of Thromboelastography During Tranexamic Acid Treatment (TTRAP-Bleeding)

Hematological Malignancies Treated With Intensive Chemotherapy

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology (SPPLAASH)

Lymphoma | Leukemia

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia (MTSA)

Acute Myeloid Leukemia

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women (HOMEORAD)

Breast Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Terminated

Post-SOPHrology Cancer Patients' anxieTY Report (SOPHTY)

Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain (CAPSONCO)

Neuropathic Pain

France
Institut de Cancérologie de la Loire
Ligue contre le cancer, France

Unknown

Nutrition and Chemotherapy (JEUNETCHIMIO)

Cancer

France
Institut de Cancérologie de la Loire
Centre Leon Berard; Hospices Civils de Lyon

Unknown

Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy (CHIMIO ORALE)

Neoplasm

France
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne; CH Roanne

Completed

Radiation Impact on Thromboembolic Events (RIT)

Malignant Neoplasm

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Groupe de Recherche sur la Thrombose

Completed

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (METRO)

Multiple Myeloma

France
Institut de Cancérologie de la Loire
Centre Leon Berard; Hospices Civils de Lyon; Société Biophoton

Completed

Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation (STOP MUCITES)

Hematologic Malignancy

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Centre Antoine Lacassagne

Terminated

GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and Tolerance (GERABEL)

Breast Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Institut de Recherche Biomedicale des...

Terminated

Validation of Radio-induced Damage Biomarkers (BIOM-DRI)

Bone Metastasis | Malignant Hemopathy

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Centre Hospitalier Emile Roux; Hôpital... and other collaborators

Completed

Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway (PARACT)

Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Université Jean Monnet de Saint-Etienne

Recruiting

Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells (MENTALO)

Malignant Hemopathy

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Laboratoire Interuniversitaire de Biologie...

Terminated

Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy (FITME)

Myelodysplatic Syndromes

France
Institut de Cancérologie de Lorraine

Recruiting

Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted. (PROTOTOX)

Quality of Life | Cancer | Hearing Disorders | Ototoxicity, Drug-Induced

France
Institut de Cancérologie de Lorraine

Not yet recruiting

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) (EFACog)

No Metastatic Breast Cancer

France
Institut de Cancérologie de Lorraine

Recruiting

Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia (PhotodiVIN)

Vulvar Intraepithelial Neoplasia | Vulvar High Grade Squamous Intraepithelial Lesion | Differentiated Vulvar Intraepithelial Neoplasia

France
Institut de Cancérologie de Lorraine

Recruiting

Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL) (PERCIMEL)

Melanoma

France
Institut de Cancérologie de Lorraine

Recruiting

Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC (PIPADN)

Peritoneal Carcinomatosis

France
Institut de Cancérologie de Lorraine

Completed

Unusual Toxicity Induced by Radiotherapy (CRYOTOX)

Cancer

France
Institut de Cancérologie de Lorraine

Completed

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure (ANIBPV)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch (ENHYZA)

Pain

France

Clinical Trials Sponsored by Institut de Cancérologie de la Loire

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations